Concepedia

Kendall M. Mohler

KM

16

Publications

3.8K

Citations

15

H-Index

1989

Active since

Affiliations

Research & Development Corporation(Current)

Eli Lilly (United States)

University of Miami

Massachusetts General Hospital

University of Texas Health Science Center at Dallas

Kendall M. Mohler is an author at Research & Development Corporation specializing in immunology, medicine, and inflammation.

Top concepts

Publications per year

1989–1999

16

Publications

16

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Larry W. Moreland, Scott W. Baumgartner, Michael Schiff et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

, , +19

TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation

Jacques J. Peschon, Dauphine Torrance, Kim L. Stocking et al. · The Journal of Immunology · 1998 · 706 citations · Full text

, , +19

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

Kendall M. Mohler, Paul R. Sleath, Jeffrey N. Fitzner et al. · Nature · 1994 · 599 citations

, , +8

CD40/CD40 ligand interactions are required for T cell‐dependent production of interleukin‐12 by mouse macrophages

Mary K. Kennedy, Kathleen S. Picha, William C. Fanslow et al. · European Journal of Immunology · 1996 · 178 citations

Induction of B cell costimulatory function by recombinant murine CD40 ligand

Mary K. Kennedy, Kendall M. Mohler, Kurt Shanebeck et al. · European Journal of Immunology · 1994 · 146 citations

, , +15

Rows per page

1–5 of 16